Your session is about to expire
← Back to Search
Behavioral Intervention
Proud & Empowered Program for Bullying in LGBTQ Youth
N/A
Recruiting
Led By Jeremy Goldbach, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and post-intervention/follow-up (12 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial found that a multi-level intervention was efficacious in reducing LGBTQ youth's experience of victimization.
Who is the study for?
This trial is for LGBTQ students in one of 24 selected high schools. It's designed to help those who might be dealing with substance use, stress from trauma, PTSD, depression, anxiety, bullying or thoughts of suicide.
What is being tested?
The 'Proud & Empowered' program is being tested to see if it can improve coping behaviors and mental health among LGBTQ youth facing various challenges like harassment and substance abuse.
What are the potential side effects?
Since this intervention involves a school program rather than medication, there are no direct medical side effects. However, participants may experience emotional discomfort when discussing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between baseline and post-intervention/follow-up (12 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and post-intervention/follow-up (12 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adapted CSSRS Suicide Questions (Columbia Suicide Severity Rating Scale)
Beck Anxiety Inventory (BAI)
Mental Depression
+3 moreSecondary study objectives
California Healthy Kids Survey General Bullying and Gender Identity/Sexual Orientation-Based Harassment Module
Youth Risk Behavior Survey Substance Use Questions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention schoolsExperimental Treatment1 Intervention
Schools will be assigned to either intervention or control schools. Students in intervention schools will receive the intervention in semester 1.
Group II: Control schoolsActive Control1 Intervention
Students in control schools will receive no intervention
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
2,000 Previous Clinical Trials
2,343,860 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
444 Previous Clinical Trials
1,413,201 Total Patients Enrolled
University of Southern CaliforniaOTHER
946 Previous Clinical Trials
1,604,169 Total Patients Enrolled
Jeremy Goldbach, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
72 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Intervention schools
- Group 2: Control schools
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.